Sleep Apnea Oral Appliances Market - Global Forecasts to 2023

Growth in this market is mainly driven by the growing popularity of oral appliances in sleep apnea management, technological advancements in oral appliances, a large pool of undiagnosed sleep apnea patients, and growing awareness about sleep apnea.

The Sleep Apnea Oral Appliances Market is projected to reach USD 482.5 Million by 2023 from an estimated USD 233.2 Million in 2018, at a CAGR of 15.7%.

Download PDF Brochure :- 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=105423877

By product, the mandibular advancement devices segment is projected to register the highest CAGR during the forecast period. The large share and high growth can be attributed to the popularity of MADs backed up by the extensive research available supporting their effectiveness over TRDs.

By type, physician-prescribed/customized oral appliances segment is projected to grow at the highest CAGR during the forecast period. The high growth can be attributed to the rising awareness of sleep apnea and increasing patient preference for prescribed and customized oral appliances.

North America is expected to account for the largest share of the sleep apnea oral appliances market in 2018. The rising prevalence of sleep apnea in the region coupled with the growing demand for alternative treatment options due to poor compliance associated with CPAP is driving the sleep apnea oral appliances market in the region. 

Read More :- 

https://www.marketsandmarkets.com/PressReleases/sleep-apnea-oral-appliances.asp

ResMed (US), SomnoMed (Australia), and Whole You (US) are the key players in the sleep apnea oral appliances market. Other players involved in this market are Oventus (Australia), Panthera Dental (Canada), Airway Management (US), Apnea Sciences (US), DynaFlex (US), OravanOSA (US), and Myerson (US).

New report examines the European Medical Devices Market worth $ 61.4 billion by 2025

Factors such as the rising geriatric population, large and established medical technology industry, increasing number of surgical procedures, growing need for cost-containment in the healthcare industry, and the availability of funding for research and product innovation are driving the growth of this market. However, fiscal unsustainability due to wasteful spending might hamper the market growth to a certain extent. 

The report "European Medical Devices Market is projected to reach USD 61.4 billion by 2025 from an estimated USD 48.9 billion in 2020, at a CAGR of 4.7% during the forecast period. 

Download PDF Brochure :- 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=241277169

Based on device type, the market has been segmented into orthopedic devices, diagnostic imaging systems, endoscopy devices, ophthalmic devices, interventional cardiology devices, cardiac monitoring and cardiac rhythm management devices, respiratory care devices, ventilators, anesthesia monitoring devices, dialysis devices, and diabetic care devices. The orthopedic devices segment accounted for the largest share of the European medical devices market in 2019. The growing incidence of orthopedic disorders such as arthritis, osteoporosis, soft-tissue injuries, and fractures among the elderly population is expected to drive the demand for orthopedic devices in Europe.

Based on end-user, the European medical devices market is segmented into hospitals and clinical care settings and home care settings. Hospitals and clinical care settings were the largest end-users of medical devices in Europe in 2019. This can largely be attributed to the financial capabilities of hospitals to purchase expensive devices as well as the availability of trained professionals in hospitals to operate these devices.

Germany accounted for the largest share of the European medical device market in 2019. The rising geriatric population and the presence of strong healthcare infrastructure in the country are the major factors that are driving the demand for medical devices in Germany.

Read More :- 

https://www.marketsandmarkets.com/PressReleases/european-medical-devices.asp

The prominent players in the global European medical device market are Siemens Healthineers (Germany), GE Healthcare (US), Philips (Netherlands), Abbott (US), Medtronic (Ireland), Stryker (US), Boston Scientific (US), Asahi Kasei Medical (Japan), B. Braun (Germany),  Baxter International, Inc. (US), ResMed (US), Masimo (US), and KARL STORZ (Germany).

Report explores the High Throughput Screening Market worth $29.29 Billion by 2027

The major factors driving the growth of the HTS market include initiatives undertaken by pharmaceutical and biotechnology companies, increasing R&D spending, technological advancements in HTS, and the availability of government funding and venture capital investments.

The High Throughput Screening Market is expected to reach USD 29.29 billion by 2027 from an estimated USD 14.95 billion in 2019, at a CAGR of 7.8%. 

Download PDF Brochure :- 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134981950

On the basis of product and service, the reagents & assay kits segment accounted for the largest share of the global HTS market. The large share of this segment can be attributed to factors such as the large numbers of reagents and assay kits used in HTS techniques, rising prevalence of a number of diseases, increasing pharmaceutical R&D, and increased government funding for life science research.

Based on technology, the HTS market is segmented into cell-based assays, lab-on-a-chip (LOC), ultra-high-throughput screening (uHTS), label-free technology, and bioinformatics. In 2018, the cell-based assays segment accounted for the largest share of the HTS market. The large share of this segment can be attributed to its increased use in cell culture techniques, especially 2D cell culture.

Based on end user, the pharmaceutical and biotechnology companies segment accounted for the largest share of the HTS market. Factors such as the increasing use of HTS techniques by pharmaceutical and biotechnology companies for drug discovery applications along with the increasing pharmaceutical R&D expenditure are driving the growth of this segment.

North America accounted for the largest share of the HTS market in 2018, followed by Europe and Asia Pacific. 

Read More:- https://www.marketsandmarkets.com/PressReleases/high-throughput-screening.asp 

The prominent players in the global HTS market are Agilent (US), Danaher (US), Thermo Fisher Scientific (US), PerkinElmer (US), Tecan (Switzerland), Axxam (Italy), Merck Group (Germany), Bio-Rad (US), Hamilton (US), Corning (US), BioTek (US), and Aurora Biomed (Canada).

Colposcopy Market - Global Forecast to 2023

The growth of this segment can be attributed to the advantages portable colposcopes offer, which include ease of installation and movement within medical settings, better result reproducibility, and the ability to produce high-definition images, and stable cervix examinations.

The Colposcopy Market is expected to reach USD 740.1 Million by 2023 from USD 532.6 Million in 2018, at a CAGR of 6.8%.

Download PDF Brochure :- 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=210884594            

The heavy burden of cervical cancer, rapidly growing geriatric population, and technological advancements in colposcopy are the key factors driving the growth of this market.

The colposcopy market is segmented on the basis of instrument type into optical colposcopes and digital colposcopes. In 2018, the optical colposcope segment is expected to account for the largest share of the colposcopy market. The large share of this segment can be attributed to advantages such as easy installation and low cost of these instruments.

On the basis of instrument portability, the market is segmented into portable, fixed, and handheld colposcopes. The portable colposcopes segment is expected to account for the largest share of the market in 2018 and it is also expected to grow at the highest CAGR during the forecast period. 

Based on region, the colposcopy market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to dominate the colposcopy market in 2018 and this trend is likely to continue during the forecast period. 

Read More :- https://www.marketsandmarkets.com/PressReleases/colposcopy.asp

Key players in the Colposcopy market include DySIS (US), CooperSurgical (US), Atmos (Germany), Olympus (Japan), Karl Kaps (Germany), McKesson (US), Danaher (US), and Carl Zeiss (Germany).

New report examines the Organs-on-chips Market worth $45.6 million by 2022

The growth of this market is mainly driven by the growing focus on developing alternatives for animal testing models, significant increase in research funding and venture capital investments for the development of organs-on-chips, technological advancements and products launches, growing number of partnerships and collaborations between pharmaceutical companies and organs-on-chips manufacturers, and growing need for early detection of drug toxicity to minimize financial losses due to late stage drug failure.

The Organs-on-chips Market is expected to reach USD 45.6 million by 2022 from USD 9.6 million in 2017, at a CAGR of 36.6%.

Download PDF Brochure :- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=144117291

Based on type, the organs-on-chips market is segmented into liver, lung, heart, kidney, and other organs-on-chips. In 2017, the accessories segment is expected to account for the largest share of the organs-on-chips market. The large share of this segment can be attributed to the simplicity of this model and the ability of on-chip hepatic tissues to maintain metabolic activity and phenotype similar to the in vivo environment.

Based on application, the organs-on-chips market is segmented into physiological model development, drug discovery, and toxicology research. The drug discovery segment is expected to register the highest CAGR during the forecast period. The increasing focus on drug discovery, rising need for more predictive in vitro tools for drug development among pharmaceutical companies, and growing preference for alternatives to conventional cell culture and animal models are some of the factors that are driving the growth of the drug discovery segment.

In 2017, North America is expected to dominate the market followed by Europe. The large share of this geographical segment is attributed to factors such as availability of new and advanced organs-on-chips in the market, and favorable government initiatives in terms of funding and programs for basic drug development and research, and the presence of key pharmaceutical companies. These are regions where the majority of drug development activity is concentrated.

Read More :- https://www.marketsandmarkets.com/PressReleases/organs-on-chips.asp

The organs-on-chips market is emerging and high growth potential market with the presence of several small players and startups firms. Some of the players in the organs-on-chips market include Emulate (US), CN Bio (UK), TissUse (Germany), Mimetas (Netherlands), InSphero (Switzerland), Ascendance Bio (US), Kirkstall (UK), HUREL (HUREL) (US), SynVivo (US), AxoSim (US), and Nortis (US).

In Vitro Diagnostics Market to Witness Steady Growth in the Near Future

Factors such as increasing burden of chronic diseases (majorly due to the rising geriatric population), rising prevalence of infectious diseases, rising demand for early disease diagnosis using specialized tests, growing awareness on personalized medicine, increasing adoption of fully-automated instruments and automation in laboratories, and increasing adoption of point-of-care testing are driving the market growth. Moreover, the introduction of a new range of condition-specific markers and tests, with advances in genomics and proteomics, is expected to offer significant growth opportunities for market players during the forecast period.

The In Vitro Diagnostics Market is projected to reach USD 106.5 billion by 2027 from USD 68.1 billion in 2018, at a CAGR of 4.9%. 

Download PDF Brochure :- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=703

Based on applications, the IVD market is segmented into diabetes, infectious diseases, oncology, cardiology, nephrology, autoimmune diseases, drug testing/pharmacogenomics, HIV/AIDS, and other applications (neurological tests, endocrine tests, blood analysis tests, pregnancy tests, and general clinical applications). The infectious diseases segment accounted for the largest share of the IVD applications market in 2017. 

Based on technology, the in vitro diagnostics market is broadly divided into immunochemistry/immunoassay, clinical chemistry, molecular diagnostics, hematology, microbiology, coagulation & hemostasis, urinalysis, and other technologies (patient self-testing, point-of-care testing, lateral flow assays, and tissue processing). The immunochemistry/immunoassay segment is expected to dominate the market in 2018. 

Based on end user, the market is segmented into laboratories (large/reference laboratories, medium-sized laboratories, and small laboratories), hospitals, academic institutes, point-of-care testing, patient self-testing, and other end users. The point-of-care testing segment is expected to grow at the highest CAGR during the forecast period. The rising prevalence of infectious diseases in developing countries and increasing incidence of cardiac diseases and diabetes are the major factors driving the demand for POC tests. 

Geographically, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2018, North America is expected to dominate the market followed by Europe. 

Read More :- 

https://www.marketsandmarkets.com/PressReleases/ivd-in-vitro-diagnostics.asp

The prominent players in the global in vitro diagnostics market include Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Abbott Laboratories (US), Thermo Fisher Scientific (US), Johnson & Johnson (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Sysmex Corporation (Japan), bioMérieux (France), DiaSorin (Italy), Ortho Clinical Diagnostics (US), Agilent Technologies (US), and QIAGEN (Germany).

Report explores the Ventilators Market worth $1.72 billion by 2027

Rising prevalence of respiratory diseases, increasing incidence of preterm births, urbanization and growing pollution levels, high prevalence of tobacco smoking, rapid growth in the geriatric population, and rising number of ICU beds are the major factors driving the growth of the ventilators market.

The report "Ventilator Market is projected to reach USD 1.72 billion by 2027 from USD 0.93 billion in 2019, at a CAGR of 8.0%.

Download PDF Brochure :- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=11018337

On the basis of interface, the invasive ventilation segment accounted for the largest share of the ventilators market. The large share of this segment is due to the high prevalence of tobacco smoking, increasing prevalence of chronic diseases such as COPD & asthma, rapid growth in the geriatric population, and improving healthcare affordability in developed countries.

On the basis of mobility, the intensive case ventilators segment accounted for the largest share of the global ventilators market. The large share of this segment is attributed to the rising number of ICU beds and rising adoption of equipping the ICU beds with ventilators.

Based on type, the adult/pediatric ventilators segment held the largest market share of ventilators market. The large share of this segment can be attributed to the large patient population with severe COPD, asthma, and other chronic respiratory diseases; rising number of smokers; and rapid growth in the geriatric population.

Based on end user, the hospitals & clinics segment accounted for the largest share of the ventilators market. The large share of this segment can be attributed to the increasing number of private and public hospitals, economic expansion and focus of government on broader healthcare policies, and increasing per capita income.

North America accounted for the largest share of the ventilators market in 2018, followed by Europe and Asia Pacific. 

Read More :- https://www.marketsandmarkets.com/PressReleases/ventilators.asp

The prominent players in the global ventilators market are Philips Healthcare (Netherlands), ResMed (US), Medtronic (Ireland), Becton, Dickinson and Company (US), Getinge (Sweden), Dräger (Germany), Smiths Group (UK), Hamilton Medical (Switzerland), GE Healthcare (US), Fisher & Paykel (New Zealand), Air Liquide (France), Zoll Medical (US), Allied Healthcare Products (US), Airon (US), Mindray (China), and Schiller (Switzerland).

Research details developments in the Flow Cytometry Market

The major factors driving the growth of the flow cytometry market are the technological advancements in flow cytometers, increasing adoption of flow cytometry techniques in research activities & clinical trials, the growing focus on immunology and immuno-oncology research, increasing incorporation of AI platforms in flow cytometry workflows & advancements in flow cytometry software, high incidence and prevalence of HIV-AIDS & cancer, and availability of novel application-specific flow cytometry products.

The global Flow Cytometry Market size is projected to reach USD 6.4 billion by 2025 from USD 4.0 billion in 2019, at a CAGR of 8.3%. 

Download PDF Brochure :- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65374584

On the basis of technology, the global market is segmented into cell-based and bead-based flow cytometry. The bead-based flow cytometry segment is estimated to witness the highest growth during the forecast period. This technology offers various procedural advantages over other cell-based assays, such as the capacity to detect multiple analytes (also known as multiplexing), high reproducibility, stability, and speed.

The market is segmented on the basis of products and services into reagents and consumables, instruments, services, software, and accessories. The reagents and consumables segment is expected to command the largest share of the global flow cytometry market in 2019. Factors such as the development and commercialization of high-quality application-specific reagents and assays and the continuous requirement of flow cytometry reagents by end users (due to the increasing number of flow cytometry-based research activities) are expected to drive the growth of the reagents and consumables market in the coming years.

Geographically, the market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America is expected to account for the largest share of the global market in 2019. 

Read More :- https://www.marketsandmarkets.com/PressReleases/flow-cytometry.asp

The major players operating in the flow cytometry market are Becton, Dickinson and Company (US), Beckman Coulter, Inc. (US), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Sysmex Partec GmbH (Germany), Luminex Corporation (US), Miltenyi Biotec GmbH (Germany), Bio-Rad Laboratories, Inc. (US), Sony Biotechnology, Inc. (US), Agilent Technologies, Inc. (US), bioMérieux S.A. (France), Enzo Life Sciences, Inc. (US), Stratedigm, Inc. (US), Cytonome/ST LLC (US), Cytek Biosciences (US), and Apogee Flow Systems Ltd. (UK).

New report examines the Ophthalmic Equipment Market worth $65.8 Billion by 2027

The growing number of people with eye diseases, technological advancement in ophthalmic equipment, and the rising adoption of contact lenses and spectacles across the globe are the major factors driving the growth of this market.

The Ophthalmic Equipment Market is projected to reach USD 65.8 Billion by 2027 from USD 56.4 Billion in 2022, at a CAGR of 3.1% during the forecast period. 

Download PDF Brochure :- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155637364

Based on diagnostic and monitoring devices type, the ophthalmic equipment market is segmented into optical coherence tomography (OCT) scanners, ophthalmic ultrasound imaging systems, fundus cameras, ophthalmoscopes, retinoscopes, wavefront aberrometers, corneal topography systems, autorefractors and keratometers, phoropters, specular microscopes, perimeter/visual field analyzers, tonometers, slit lamps, lensmeters, optical biometry systems, and chart projectors. The OCT scanners segment accounted for the major share of the ophthalmology diagnostic and monitoring devices market and this segment is expected to register the highest growth during the forecast period. 

On the basis of ophthalmology surgical devices type, the ophthalmic equipment market is segmented into cataract surgical devices, glaucoma surgical devices, refractive surgical devices, vitreoretinal surgical devices, ophthalmic microscopes, and accessories. The cataract surgical devices segment accounted for the major share of the ophthalmology surgical devices market. The large share of this segment is majorly attributed to the growing number of eye disorders in the geriatric population. 

North America is expected to account for the largest share of the ophthalmic equipment market in 2022, followed by Europe. The large share of this region is attributed to the presence of developed healthcare systems in the US & Canada, increasing number of eye disorders along with rising aging population, and availability of technologically advanced ophthalmic devices.

Read More :- https://www.marketsandmarkets.com/PressReleases/ophthalmology-devices.asp

The prominent players in the ophthalmic equipment market are Essilor (France), Alcon (Switzerland), Johnson & Johnson Vision Care (US), Bausch + Lomb (US), Haag-Streit (Switzerland), TOPCON (Japan), Carl Zeiss Meditec (Germany), NIDEK (Japan), STAAR Surgical (US), HOYA (Japan), and Ziemer Ophthalmic Systems (Switzerland)

Particle Size Analysis Market to Witness Steady Growth in the Near Future

The major factors driving the growth of the particle size analysis market include increasing research activities in the field of nanotechnology; technological advancements in particle size analyzers; increasing investment in pharmaceutical R&D; and stringent regulatory guidelines for product quality across industries.

The global Particle Size Analysis Market is expected to reach USD 524.3 Million by 2027 from USD 314.3 Million in 2017, at a CAGR of 5.2%.

Download PDF Brochure :- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=74084833

The particle size analysis market is segmented on the basis of product into segmented into laser diffraction, dynamic light scattering (DLS), imaging, nanotechnology particle analysis (NTA), the Coulter principle, and other technologies (resonant mass measurement, laser obscuration, sedimentation, and sieve analysis). The imaging technology segment is further subsegmented into dynamic and static imaging. The laser diffraction technology segment commanded the largest share of the global partcile size analysis market in 2017. The large share of this segment is attributed to laser diffraction’s wide dynamic measurement range, a feature that significantly increases its application areas.

Based on the type of industry, the global particle size analysis market is classified into five major segments—healthcare; chemicals and petroleum; mining, minerals, and cement; food and beverage; and other industries. The last segment comprises industries related to inks, toners, paint, coatings, cosmetics, and environmental analysis. The helathcare industry segment is expected to account for the largest share of the particle size analysis market in 2017 due to its dominance can be attributed to the increasing applications of nanotechnology in medical science, the rapid growth of pharmaceuticals in the healthcare industry.

Geographically, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to account for the largest share of the global particle size analysis market during the forecast period (2017-2022). 

Read More :- https://www.marketsandmarkets.com/PressReleases/particle-size-analysis.asp

The major players operating in the particle size analysis market include Malvern Instruements Limited (UK), HORIBA, Ltd. (Japan), and Beckman Coulter, Inc. (US).